All Global Research articles can be read in 27 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).
Pfizer and Moderna mRNA inoculations aren’t what they’re promoted to be.
As medically defined by the CDC, vaccines are supposed to stimulate the “immune system to produce immunity to a specific disease.”
Immunization is a “process by which a person becomes protected against a disease through vaccination.”
The above is not what mRNA inoculations are designed to do. They’re something else entirely.
They’re gene modifying delivery systems that don’t produce immunity —what Moderna calls “gene therapy technology.”
Not designed to prevent seasonal flu-renamed covid illness, at most they may somewhat reduce symptoms short-term.
Promoting mRNA technology as vaccine protection from covid is part of a state-approved/media proliferated mass deception scam.
The above technology is unapproved by the FDA for human use because it’s experimental, inadequately tested, and high-risk — especially for the elderly with weakened immune systems.
The nanoparticle-based delivery system is unapproved.
mRNA inoculations contain hazardous polyethylene glycol (PEG) to deliver their DNA-altering technology to human cells.
The risk of adverse events increases greatly from follow-up inoculations, including to potentially life-threatening anaphylactic shock.
In 2017, Moderna abandoned mRNA technology and lipid nanoparticles because tests caused large numbers of adverse effects.
Yet the same gene therapy and nanoparticle delivery system are used by Moderna and Pfizer in their misnamed mRNA “vaccines” that aren’t what they’re called.
According to statnews.com, “mRNA is a tricky technology.”
“Several major pharmaceutical companies have tried and abandoned the idea, struggling to get mRNA into cells without triggering nasty side effects.”
“(N)anoparticles created a daunting challenge: Dose too little, and you don’t get enough enzyme to affect the disease.”
“(D)ose too much, and the drug is too toxic for patients.”
“Moderna could not make its therapy work, former employees and collaborators said.”
“The safe dose was too weak, and repeat injections of a dose strong enough to be effective had troubling effects on the liver in animal studies.”
Moderna earlier admitted that its lipid nanoparticles (LNP) risked “significant adverse events,” adding:
“No mRNA drug has been approved in this new potential category of medicines,